824. Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience

BACKGROUND: Invasive mucormycosis continues to be associated with high rates of mortality despite advances in management strategies. Recent studies have suggested a benefit to early combination therapy, but overall, the data remain limited regarding its impact on outcomes. METHODS: We conducted a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Brian, Ha, David R, Shen, Sa, Ferguson, Jessica, Kim, Ailin, Kim, Sarah, Mui, Emily, Deresinski, Stan, Holubar, Marisa, Alegria, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677829/
http://dx.doi.org/10.1093/ofid/ofad500.869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677829/
http://dx.doi.org/10.1093/ofid/ofad500.869

Ejemplares similares